Loading cancer entity…
Loading cancer entity…
Clinical trials
12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05983159 | A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations(TARGET-VM) | recruiting | Phase 2 | 50 | Murdoch Childrens Research InstituteOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT06239480 | SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations(SELVA) | active not recruiting | Phase 3 | 51 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07477548 | A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies | not yet recruiting | Phase 2 | 67 | Yonsei UniversityOTHER | 0 | Mar 17, 2026 | clinicaltrials |
Data updated 22 days agoSource updated May 5, 2026source: clinicaltrials
| NCT00975819 |
| Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies |
| completed |
| Phase 2 |
| 61 |
| Denise Martin AdamsOTHER |
| 1 |
| Jan 6, 2026 |
| clinicaltrials |
| NCT06943703 | Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma | completed | — | 809 | National Children's Hospital, VietnamOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06892964 | Institution of an Italian Registry and Biobank for Biological Sample Collection(IReg-LM) | recruiting | N/A | 70 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT05050149 | Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations | completed | Phase 2 | 12 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06257719 | Clinical Characteristics of Lymphatic Malformations | completed | — | 320 | West China HospitalOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT03941782 | Compassionate Use of BYL 719 Alpelisib | no longer available | — | — | New Mexico Cancer Research AllianceOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT06160739 | Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations | unknown | — | 10 | Sohag UniversityOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT03651375 | Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall(UN-RESARC) | unknown | Phase 2 | 46 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT01290484 | A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations | completed | Phase 1 / Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 19, 2015 | clinicaltrials |